The Australian Securities Exchange (ASX), after extensive industry consultation has just issued a revised "Code of Best Practice" for Reporting by Life Science Companies (Code).

While adoption of the new Code is not mandatory, it provides a very useful tool for listed life sciences companies to discharge their continuous disclosure obligations under the ASX Listing Rules (which have the force of law pursuant to the Corporations Act).